Back to News
Market Impact: 0.3
iRhythm Completes Acquisition of VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care
Source: GlobeNewswire
M&A & RestructuringHealthcare & BiotechTechnology & InnovationCompany Fundamentals
iRhythm Holdings completed its previously announced acquisition of VitalConnect, a wearable biosensor and ambulatory cardiac monitoring company. The announcement provides no deal value or other financial terms.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
IRTC0.65
More News
- Samsung, SK Hynix shares drop as Q3 earnings loom
- DeepSeek set to raise at least $12 bln in Tencent, CATL-led round- Bloomberg
- CH Robinson to Buy RXO for $5.8B in Bet on AI Model
- Security researcher claims to they found KVM guest-host escape flaw
- BPCE acquires 7% stake in Spain’s Banco Sabadell
- Wells Fargo gets a bold upgrade ahead of earnings. Why the stock can play catch-up
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AI Financial Research Benchmarks: What the Scores Mean
- State of M&A and Private Markets, June 2026: A $4.9 Trillion Rebound, Underwritten on Money That Never Got Cheaper